| Literature DB >> 30359877 |
V Alexandra Moser1, Amy Christensen2, Jiahui Liu2, Amanda Zhou2, Shunya Yagi3, Christopher R Beam4, Liisa Galea3, Christian J Pike5.
Abstract
Risk for Alzheimer's disease (AD) is affected by multiple factors, including aging, obesity, and low testosterone. We previously showed that obesity and low testosterone independently and interactively exacerbate AD-related outcomes in young adult rodents. The goals of the present study are two-fold: to examine whether the effects of an obesogenic diet differ with increasing age and to determine if testosterone treatment in middle-aged and aged animals mitigates negative effects of the diet. Male brown Norway rats were maintained on control or high-fat diets for 12 weeks beginning in young adulthood, middle age, or advanced age. Separate cohorts of middle-aged and aged animals were treated with testosterone during dietary manipulations. Endpoints included metabolic indices, inflammation, cognitive performance, and neural health outcomes. Aging was associated with poorer outcomes that were generally exacerbated by high-fat diet, especially at middle age. Testosterone treatment was largely without benefit, exerting only subtle effects on a select number of measures. Understanding how the deleterious effects of obesity are affected by advancing age and the ability of protective strategies such as testosterone to reduce these effects may provide significant insight into both the development and prevention of age-related cognitive decline and AD.Entities:
Keywords: Aging; Diet-induced obesity; High-fat diet; Neuroinflammation; Testosterone
Mesh:
Substances:
Year: 2018 PMID: 30359877 PMCID: PMC6252085 DOI: 10.1016/j.neurobiolaging.2018.09.016
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673